2021

Introduction of the ROCHE Cobas Assay with improved sensitivity in detecting HBV DNA. With the availability of this diagnostic test, the understanding of the unmet medical need in HBV increased as it demonstrated that NAs were not reducing HBV DNA as much as previously thought.